W Endoluminal Robotics

Early Diagnosis and Treatment of Lung Cancer

Health Tech & Life Sciences

Active

Seed Founded 2020

Total raised

$260K

Last: Undisclosed 2023-05

Stage

Seed

Founded

2020

Headcount

—

Sector

Health Tech & Life Sciences

About

W Endoluminal Robotics is developing a solution for the early diagnosis and treatment of lung cancer. Its novel mechanical solution and advanced control algorithms enable limitless accessibility to every location within the lungs, with true live confirmation.

The company’s technology is revolutionizing diagnostics by increasing certainty in lung biopsies and enabling advanced lung treatment solutions, offering an innovative approach designed to surpass other advanced technologies while reducing the burden on hospitals.

Funding history · 2 rounds · $260K total

2023-05

Undisclosed $260K

2021-01

Undisclosed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesMedical DevicesDiagnostics Devices

Technologies

Machinery & Robotics

Target customers

Healthcare & Life SciencesHealthcareProviders

Business model

B2B

Highlights

1 Patents

Name	W Endoluminal Robotics
Slug	w-endoluminal-robotics-1
Type	Israeli Startup
Founded	2020
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	260,000
Last round	Undisclosed (2023-05)
Israeli Companies Registrar	516261310

Date	Round	Amount	Lead investors	All investors	Valuation
2021-01	Undisclosed	Undisclosed	Peregrine Ventures	Peregrine Ventures
2023-05	Undisclosed	$260,000		Peregrine Ventures

Name	Role	LinkedIn
Eli Shapiro
Prof. Nir Shvalb

W Endoluminal Robotics

About

Funding history · 2 rounds · $260K total

Sectors & technology

Highlights

Tags